12 Health Care Stocks Moving In Tuesday's Intraday Session
I'm LongbridgeAI, I can summarize articles.During Tuesday's intraday session, several healthcare stocks experienced significant volatility. Crinetics Pharmaceuticals surged 98.7% to $83.53, while Tvardi Therapeutics rose 40.04%. Other gainers included Akari Therapeutics and Bluejay Diagnostics. Conversely, Basel Medical Group fell 15.2%, with YD Bio and Conexeu Sciences also declining over 14%. The report highlights major price movements in the healthcare sector.
Gainers
- Crinetics Pharmaceuticals (NASDAQ:CRNX) shares moved upwards by 98.7% to $83.53 during Tuesday's regular session. The company's market cap stands at $4.4 billion.
- Tvardi Therapeutics (NASDAQ:TVRD) stock moved upwards by 40.04% to $2.81. The company's market cap stands at $18.8 million.
- Akari Therapeutics (NASDAQ:AKTX) shares increased by 32.75% to $14.47. The company's market cap stands at $19.0 million.
- Bluejay Diagnostics (NASDAQ:BJDX) stock moved upwards by 31.03% to $1.52. The market value of their outstanding shares is at $1.2 million.
- Veraxa Biotech Holding (NASDAQ:VRXA) shares moved upwards by 21.0% to $2.65. The company's market cap stands at $309.6 million.
- Pyxis Oncology (NASDAQ:PYXS) shares increased by 19.71% to $2.94. The market value of their outstanding shares is at $155.8 million.
Losers
- Basel Medical Group (NASDAQ:BMGL) shares fell 15.2% to $5.97 during Tuesday's regular session. The company's market cap stands at $11.0 million.
- YD Bio (NASDAQ:YDES) stock declined by 14.96% to $1.99. The market value of their outstanding shares is at $165.7 million.
- Conexeu Sciences (NASDAQ:CNXU) shares decreased by 14.26% to $9.26. The market value of their outstanding shares is at $288.9 million.
- Axe Compute (NASDAQ:AGPU) shares fell 12.49% to $7.36. The company's market cap stands at $95.7 million.
- CollPlant Biotechnologies (NASDAQ:CLGN) stock declined by 12.33% to $0.38. The market value of their outstanding shares is at $5.4 million.
- Forum Markets (NASDAQ:FRMM) shares fell 12.05% to $5.99. The company's market cap stands at $89.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.